Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release...
Strong operational execution results in thirteenth consecutive quarter of year-over-year revenue and net income growth
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release...
New Prague, Minnesota--(Newsfile Corp. - November 20, 2025) - Electromed, Inc. (NYSE American: ELMD) ("Electromed" or the "Company"), a leader in innovative airway clearance technologies, today announced...
Strong operational execution results in twelfth consecutive quarter of year-over-year revenue and net income growth
Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release...
In a report released today, Kyle Bauser from Roth MKM reiterated a Buy rating on Electromed, with a price target of $35.00. The company’s shares closed last Friday at $24.10.Elevate Your Investing Strategy:...
Management will present Monday, October 20, 2025 at 10:00 am PTNew Prague, Minnesota--(Newsfile Corp. - October 13, 2025) - Electromed, Inc. (NYSE American: ELMD) ("Electromed" or the "Company"), a leader...
Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that on September 9, 2025, its Board of Directors authorized Electromed...
Record quarterly and annual revenues and operating income, marking the eleventh consecutive quarter of year-over-year revenue and operating income growth ...